Nephros Inc.
NEPH | NASDAQ
$3.17
-$0.10 (-3.06%)
At close: Oct 30, 2026, 4:00 PM ET
$3.15
-$0.02 (-0.54%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 18.79M | 14.16M | 14.24M | 9.98M | 10.22M | 8.56M |
Cost of Revenue | 7.3M | 5.44M | 5.83M | 5.24M | 4.58M | 3.65M |
Gross Profit | 11.49M | 8.72M | 8.41M | 4.73M | 5.63M | 4.91M |
Operating Income | 1.15M | 6K | -1.59M | -4.34M | -3.25M | -4.28M |
Interest Income | 139K | 94K | 64K | 14K | 10K | 11K |
Pretax Income | 1.21M | 89K | -1.58M | -4.28M | -2.78M | -4.53M |
Net Income | 1.19M | 74K | -1.58M | -7.38M | -4.11M | -4.77M |
Selling & General & Admin | 9M | 7.68M | 8.91M | 7.59M | 7.2M | 6.47M |
Research & Development | 1.34M | 906K | 873K | 1.26M | 1.5M | 2.76M |
Other Expenses | n/a | 135K | 214K | 218K | 192K | -37K |
Operating Expenses | 10.34M | 8.72M | 10M | 9.07M | 8.89M | 9.19M |
Interest Expense | 1K | 1K | 2K | 20K | 41K | 110K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.64M | 14.16M | 15.83M | 14.31M | 13.47M | 12.84M |
Income Tax Expense | 12K | 15K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 10.61M | 10.53M | 10.39M | 10.3M | 10.02M | 9.08M |
Shares Outstanding (Diluted) | 10.97M | 10.6M | 10.39M | 10.3M | 10.02M | 9.08M |
EPS (Basic) | 0.11 | 0.01 | -0.15 | -0.72 | -0.41 | -0.52 |
EPS (Diluted) | 0.11 | 0.01 | -0.15 | -0.72 | -0.41 | -0.52 |
EBITDA | 1.35M | 227K | -1.36M | -3.69M | -2.49M | -4.21M |
EBIT | 1.21M | 90K | -1.57M | -4.26M | -2.74M | -4.42M |
Depreciation & Amortization | 140K | 137K | 214K | 571K | 252K | 208K |
Add to Watchlist
Select watchlists to add or remove NEPH